Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of plants as hosts in expressing rituximab

A technology of rituximab and an expression vector is applied in the application field of plants as hosts in the expression of rituximab antibodies, and can solve the problems of high production cost, high price, low production capacity of animal cells and the like

Active Publication Date: 2022-05-20
SAGACITY FAITHFUL CONVERGENCE HEALTH TECH LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, animal cell culture requires expensive culture medium, strict factory conditions, complex operations, and a time period of at least two weeks, and the production capacity of animal cells is low, and the production cost is extremely high
Sometimes the virus carried by animal cells can infect humans, and the safety is low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of plants as hosts in expressing rituximab
  • Application of plants as hosts in expressing rituximab
  • Application of plants as hosts in expressing rituximab

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] The construction of embodiment 1 plant transient expression vector

[0049] In order to provide high-efficiency expression of foreign protein in plants, the amino acid sequence of human rituximab antibody heavy chain, light chain (https: / / www.drugbank.ca / drugs / DB00073) was reverse-translated software (https: / / www .idtdna.com / CodonOpt) to obtain the nucleotide sequence and optimize its codons to plant-preferred codons, which were synthesized by GenScript (Nanjing, China). An Xbal restriction site was added to the 5' end of the optimized rituximab heavy chain sequence, and a SacI site was added to the 3' end. A Xbal restriction site was added to the 5' end of the rituximab light chain sequence, and a Sacl site was added to the 3' end. and cloned into the pUC57 vector by GenScript Company to obtain pRit-H and pRit-L cloning vectors respectively ( figure 1 ), the gene fragments were separated from the cloning vector by Xbal / Sacl, and cloned into the binary plant vector, p...

Embodiment 2

[0050] Example 2 Agrobacterium-mediated vacuum infiltration

[0051] Mix the prepared Agrobacteria containing p35S-Rit-H and p35S-Rit-L in equal amounts until the O.D.600 is 0.5. The culture suspension was placed in a 2L beaker and placed in a desiccator. The lettuce kept in this laboratory was turned upside down (core up) and gently swirled in the bacterial suspension, and the desiccator was sealed. The vacuum pump (Welch Vacuum, Niles, IL, USA) was turned on to evacuate and the permeate was seen in the leaf tissue. Hold the pressure for 30-60 seconds. The system is quickly opened to release the pressure and allow permeate to seep into the spaces within the tissue. This process was repeated 2 to 3 times until the penetration of the permeate into the lettuce tissue was clearly visible. The lettuce tissue was then gently removed from the permeate and rinsed three times consecutively with distilled water before being transferred to a container covered with plastic film. The...

Embodiment 3

[0052] Example 3 Protein Extraction and Separation

[0053] Lettuce samples vacuum-infiltrated with Agrobacterium were stirred with a stirrer and homogenized in a mixer at high speed for 1-2 minutes with an extraction buffer (100mM KPi, pH7.8; 5mM EDTA; 10mM β-mercaptoethanol) with a volume ratio of 1:1 . The homogenate was adjusted to pH 8.0, filtered through gauze, and the filtrate was centrifuged at 10,000 g for 15 minutes at 4°C to remove cell debris. The supernatant was collected, mixed with ammonium sulfate (50%), and incubated with shaking on ice for 60 minutes. Centrifuge again (10,000g) for 15 minutes at 4°C. The obtained supernatant was subjected to a second round of ammonium sulfate (70%) precipitation, suspended by shaking on ice for 60 minutes, and centrifuged again at 10,000 g at 4°C for 15 minutes. Then, the supernatant was discarded, and the protein precipitated from the treated samples was dissolved in 5 mL of buffer (20 mM KPi, pH 7.8; 2 mM EDTA; 10 mM β-m...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of biotechnology, in particular to the application of plants as hosts for expressing rituximab antibodies. The present invention uses plants such as lettuce as an effective expression platform for recombinant protein production, and uses a simple and effective Agrobacterium-mediated vacuum infiltration method to express rituximab (Rituximab, Rituxan, MabThera). This expression system confirms that the plant exogenous protein can be collected 4 days after Agrobacterium infection. The successful expression of the recombinant rituximab was confirmed by SDS‑PAGE. Burkitt's lymphoma inhibition experiment proved that the rituximab produced by lettuce has the biological activity of inhibiting lymphoma cells.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to the application of plants as hosts in expressing rituximab antibodies. Background technique [0002] Lymphoma is a type of malignant blood tumor. From the perspective of morbidity and mortality, according to the data of "China Tumor Registration Annual Report", the incidence rate of malignant lymphoma was about 6.68 / 100,000 from 2003 to 2013, and the number of new cases each year was nearly 90,000, ranking among all malignant lymphomas. The eighth place in cancer incidence. The incidence rate of men is higher than that of women, and the fatality rate is 3.75 / 105, ranking tenth. From the perspective of disease classification, lymphoma is usually divided into two categories: Hodgkin's lymphoma (HL accounts for 10% of all lymphomas) and non-Hodgkin's lymphoma (NHL, accounts for 90% of all lymphomas) , a total of more than 70 subtypes. [0003] Rituximab (Rituximab, Rituxan, MatThera...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/28C12N15/82C12P21/00
CPCC07K16/2887C12N15/8258C12P21/00C07K2317/13C07K2317/24C07K16/28C12N15/82
Inventor 王跃驹陈书元陈雪
Owner SAGACITY FAITHFUL CONVERGENCE HEALTH TECH LTD